Clinical Trial Update: Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the biological standardization of Dermatophagoides pteronyssinus allergen extract has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Allergic Rhinitis

Drugs mentioned

• Dermatophagoides pteronyssinus allergen extract (house dust mite allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergy Dermatophagoides Pteronyssinus, Allergic Rhinitis | Phase 2 | Status: COMPLETED